drugset / Trial / NCT00882050
Intravenous Exenatide (Byetta) During Surgery
Phase 1/2
Completed
104 enrolled
Thomas Jefferson University
Amylin Pharmaceuticals, LLC. · collabEli Lilly and Company · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this project is to study if intravenous Exenatide is effective at maintaining normal blood glucose levels and preventing low blood glucose levels during surgery.
Timeline
- Start
- 2009-03
- Primary completion
- 2016-04
- Completion
- 2016-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Exenatide | Peptide | 0.27 unknown | Intravenous |
| Subject | Exenatide | Peptide | 0.41 unknown | Intravenous |